ILLUCCIX

Product Overview

About ILLUCCIX

ILLUCCIX is a radiopharmaceutical agent containing the active ingredient GALLIUM (68Ga) GOZETOTIDE. It is used in nuclear medicine for diagnostic imaging purposes, specifically for the detection and localization of neuroendocrine tumors.

Key Benefits & Uses

• Diagnosis of neuroendocrine tumors, including pancreatic neuroendocrine tumors (PNETs) and other neuroendocrine neoplasms
• Localization of neuroendocrine tumors for surgical planning and treatment
• Assessment of tumor burden and response to therapy

Active Ingredient & Action

GALLIUM (68Ga) GOZETOTIDE is a gallium-based radiopharmaceutical that selectively binds to somatostatin receptors on the surface of neuroendocrine tumor cells. This binding allows for the accumulation of the radiolabelled compound in tumor tissues, enabling visualization and detection using positron emission tomography (PET) imaging.

Important Notes

ILLUCCIX should only be administered by a qualified healthcare professional in a licensed nuclear medicine facility. Patients should be counseled on the potential risks and benefits of the procedure, including radiation exposure and potential allergic reactions. Appropriate safety precautions and radiation protection measures should be taken during administration and handling of the product.